4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-066175
Director sold 10,497 shares at an average $75.17 ($789,107)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2024-05-28 | Sale 10b5-1 | −5,249 | $75.21 | $394,775 | 19,848 | D |
| Coleman Mark Director | 2024-05-29 | Sale 10b5-1 | −5,248 | $75.14 | $394,333 | 14,600 | D |
| Open-market sales · 10,497 sh · avg $75.17 · $789,107 | |||||||
Loading xslF345X05/ownership.xml…